James E. Gottesman, M.D., is one of the two distinguished board-certified urologists who perform no-scalpel, no-needle vasectomies at the Vasectomy Center at Swedish Issaquah and Swedish Greenlake Clinics. The no-needle technique is the most advanced — and most comfortable — no-scalpel method available on the market today. Dr. Gottesman and his partner, Wayne D. Weissman, M.D., were among the first of a growing number of physicians in Washington who offer no-scalpel, no-needle vasectomies. Combined, they have more than 50 years of experience in the practice of medicine and have performed more than 12,000 vasectomies. A board-certified urologist, Dr. Gottesman attended the University of California at Berkeley and graduated from the University of California, San Francisco Medical School (UCSF) in 1970 with honors. He was also a member of the Alpha Omega Alpha Honorary Society. He completed his general surgical training at UCSF and served his residency in urology at the University of California at Los Angeles under the prestigious Drs. Joseph Kaufman and Willard Goodwin. From 1972 to 1976, Dr Gottesman performed vasectomies at the Planned Parenthood Vasectomy Clinic. In 1978, after two years on the faculty at Rush Medical School in Chicago, he and his family moved to Seattle and began practice at Swedish Medical Center. Dr. Gottesman is clinical professor of urology at the University of Washington and has authored more than 65 papers and five book chapters. He is past chief of the department of urology at Swedish. He has two patents on urological devices and has written many medical educational software programs, including the original program of Dialog Medical, called DISCussion. He has been selected on multiple occasions by the physicians of King County as one of region’s ‘Top Doctors in Seattle Magazine, and in the Fall 2003 issue of Puget Sound Consumers’ Checkbook. Besides his clinical interest vasectomy, Dr. Gottesman was active in the treatment of all genitourinary malignancies, (kidney, ureter, bladder, prostate and testes) and was a principal investigator for the National Prostate Cancer Prevention Study and multiple investigational drug studies.